Cardiothoracic manifestations of neuroendocrine tumours

被引:8
作者
Mandegaran, Ramin [1 ]
David, Sarojini [2 ]
Screaton, Nicholas [3 ]
机构
[1] Guys & St Thomas NHS Fdn Trust, Dept Radiol, London, England
[2] Lewisham & Greenwich NHS Trust, Univ Hosp Lewisham, Dept Radiol, London, England
[3] Papworth Everard Hosp, Papworth Hosp NHS Fdn Trust, Dept Radiol, Cambridge, England
关键词
CARCINOID HEART-DISEASE; CELL LUNG-CANCER; IDIOPATHIC DIFFUSE HYPERPLASIA; ENDOCRINE NEOPLASIA TYPE-1; 3-DIMENSIONAL ECHOCARDIOGRAPHY; THYMIC CARCINOIDS; CT; CLASSIFICATION; MANAGEMENT; SPECTRUM;
D O I
10.1259/bjr.20150787
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Cardiothoracic neuroendocrine tumour (NET) manifestations encompass a vast disease spectrum. Pulmonary neuroendocrine tumours represent a range of tumour grade and differentiation characteristics from pre-malignant diffuse neuroendocrine cell hyperplasia, well-differentiated, low-grade carcinoid tumours with excellent outcomes, through to high-grade small-cell lung carcinoma and large-cell neuroendocrine carcinoma with poor prognoses. Rarer thymic NETs represent a similarly wide neoplastic spectrum. Cardiac carcinoid is a paraneoplastic manifestation of the carcinoid syndrome and often the cause of mortality in NETs with hepatic metastases. Cardiothoracic NET manifestations are reviewed herein from a radiologists' perspective, discussing the diverse clinical presentations, spectrum of neoplastic and paraneoplastic manifestations, imaging features and treatment options.
引用
收藏
页数:14
相关论文
共 103 条
  • [41] 2
  • [42] 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and CT
    Gabriel, Michael
    Decristoforo, Clemens
    Kendler, Dorota
    Dobrozemsky, Georg
    Heute, Dirk
    Uprimny, Christian
    Kovacs, Peter
    Von Guggenberg, Elisabeth
    Bale, Reto
    Virgolini, Irene J.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) : 508 - 518
  • [43] Gandhi Leena, 2006, J Natl Compr Canc Netw, V4, P631
  • [44] Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1
    Gibril, F
    Chen, YJ
    Schrump, DS
    Vortmeyer, A
    Zhuang, ZP
    Lubensky, IA
    Reynolds, JC
    Louie, A
    Entsuah, LK
    Huang, K
    Asgharian, B
    Jensen, RT
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) : 1066 - 1081
  • [45] Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia as a precursor to pulmonary neuroendocrine tumors
    Gosney, JR
    [J]. CHEST, 2004, 125 (05) : 108S - 108S
  • [46] Octreoscan in patients with bronchial carcinoid tumours
    Granberg, D
    Sundin, A
    Janson, ET
    Öberg, K
    Skogseid, B
    Westlin, JE
    [J]. CLINICAL ENDOCRINOLOGY, 2003, 59 (06) : 793 - 799
  • [47] Bronchopulmonary neuroendocrine tumors
    Gustafsson, Bjorn I.
    Kidd, Mark
    Chan, Anthony
    Malfertheiner, Max V.
    Modlin, Irvin M.
    [J]. CANCER, 2008, 113 (01) : 5 - 21
  • [48] Clinical outcomes of atypical carcinoid tumors of the lung and thymus: 7-year experience of a rare malignancy at single institute
    Han, Boram
    Sun, Jong-Mu
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    [J]. MEDICAL ONCOLOGY, 2013, 30 (01)
  • [49] Ito T, 1997, LAB INVEST, V77, P449
  • [50] Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity
    Iyoda, A
    Hiroshima, K
    Moriya, Y
    Mizobuchi, T
    Otsuji, M
    Sekine, Y
    Shibuya, K
    Iizasa, T
    Saitoh, Y
    Fujisawa, T
    [J]. ANNALS OF THORACIC SURGERY, 2004, 77 (06) : 1891 - 1895